1Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors [ J ]. Endo- crinol Metab Clin North Am, 2011, 40 (1) : 1-18,.
2vii. Yao JC, Hassan M, Phan A, et al. One hundred years after " carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J]. J Clin Oncol, 2008, 26 (18): 5063-3072.
3Luke C, Price T, Townsend A, et al. Epidemiology of neuroendocrine cancers in an Australian population [ J ]. Cancer Causes Control, 2010, 21 (6): 931-938.
4Hauso O, Gustafsson BI, Kidd M, et ah Neuroendocrine tumor epidemiology: contrasting Norway and North America [J]. Cancer, 2008, 113 (10): 2655-2664.
5Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in ]apun [J]. J Gastroenterol, 2010, 45 (2): 234-243.
7Turaga KK, Kvols LK. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuro- endocrine tumors[J]. CA Cancer J Clin, 2011, 61 (2) : 113-132.
8Rossi RE,Massironi S,Spampatti MP,et al. Treatment of LiverMetastases in Patients with Digestive Neuroendocrine Tumors[J]. Journal of gastrointestinal surgery, 2012 ,16 ( 10) : 1 981-1992.
9Poncet G,Villaume K,Walter T,et al. Angiogenesis and tumorprogression in neuroendocrine digestive tumors[J]. Journal ofSurgical Research,2009,154(1) :68-77.
